Alzheimer's Drug Rejected
This is a UK news story, published by Guardian, that relates primarily to Donanemab news.
UK news
For more UK news, you can click here:
more UK newsDonanemab news
For more Donanemab news, you can click here:
more Donanemab newsdrug discoveries news
For more drug discoveries news, you can click here:
more drug discoveries newsGuardian news
For more news from Guardian, you can click here:
more news from GuardianAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
new Alzheimer. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest stage Alzheimer news, many promising treatments news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
AlzheimerGuardian
•Which disease-modifying Alzheimer’s drugs are the most promising?
80% Informative
Donanemab and lecanemab were approved by the UK ’s Medicines and Healthcare products Regulatory Agency.
Yet the National Institute for Health and Care Excellence (Nice ) said their benefits were too small to justify their costs.
There have also been concerns over potential side-effects such as brain swelling and bleeding.
VR Score
74
Informative language
68
Neutral language
71
Article tone
semi-formal
Language
English
Language complexity
55
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
5
Affiliate links
no affiliate links